These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 26092189)
1. Super short membrane-active lipopeptides inhibiting the entry of influenza A virus. Wu W; Wang J; Lin D; Chen L; Xie X; Shen X; Yang Q; Wu Q; Yang J; He J; Liu S Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2344-50. PubMed ID: 26092189 [TBL] [Abstract][Full Text] [Related]
2. A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities. Lin D; Li F; Wu Q; Xie X; Wu W; Wu J; Chen Q; Liu S; He J Sci Rep; 2016 Mar; 6():22790. PubMed ID: 26952867 [TBL] [Abstract][Full Text] [Related]
3. Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin. Lin D; Luo Y; Yang G; Li F; Xie X; Chen D; He L; Wang J; Ye C; Lu S; Lv L; Liu S; He J Biochem Pharmacol; 2017 Nov; 144():35-51. PubMed ID: 28774731 [TBL] [Abstract][Full Text] [Related]
4. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025 [TBL] [Abstract][Full Text] [Related]
5. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin. Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526 [TBL] [Abstract][Full Text] [Related]
6. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus. Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430 [TBL] [Abstract][Full Text] [Related]
7. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783 [TBL] [Abstract][Full Text] [Related]
8. [3-O-β-chacotriosyl benzyl ursolate inhibits entry of H5N1 influenza virus into target cells]. Song G; Shen X; Li Y; Zheng Y; Xiong P; Liu S Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):789-94. PubMed ID: 26111672 [TBL] [Abstract][Full Text] [Related]
9. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides. Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus. Ding N; Chen Q; Zhang W; Ren S; Guo Y; Li Y Eur J Med Chem; 2012 Jul; 53():316-26. PubMed ID: 22575533 [TBL] [Abstract][Full Text] [Related]
11. Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell. Zhu Z; Yao Z; Shen X; Chen Z; Liu X; Parquette JR; Liu S Eur J Med Chem; 2017 Apr; 130():185-194. PubMed ID: 28246043 [TBL] [Abstract][Full Text] [Related]
13. Antiviral properties of extracts of Streptomyces sp. SMU 03 isolated from the feces of Elephas maximus. Li F; Lu S; Xie X; Fan S; Chen D; Wu S; He J Fitoterapia; 2020 Jun; 143():104600. PubMed ID: 32330578 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors. Song G; Shen X; Li S; Li Y; Si H; Fan J; Li J; Gao E; Liu S Eur J Med Chem; 2016 Aug; 119():109-21. PubMed ID: 27153348 [TBL] [Abstract][Full Text] [Related]
15. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion. Wu G; Yu G; Yu Y; Yang S; Duan Z; Wang W; Liu Y; Yu R; Li J; Zhu T; Gu Q; Li D J Med Chem; 2020 Jul; 63(13):6924-6940. PubMed ID: 32520560 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of 3-O-β-chacotriosyl ursolic acid derivatives as novel H5N1 entry inhibitors. Song G; Shen X; Li S; Li Y; Liu Y; Zheng Y; Lin R; Fan J; Ye H; Liu S Eur J Med Chem; 2015 Mar; 93():431-42. PubMed ID: 25728024 [TBL] [Abstract][Full Text] [Related]
17. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus. Hussein AFA; Cheng H; Tundup S; Antanasijevic A; Varhegyi E; Perez J; AbdulRahman EM; Elenany MG; Helal S; Caffrey M; Peet N; Manicassamy B; Rong L Antiviral Res; 2020 May; 177():104782. PubMed ID: 32222293 [TBL] [Abstract][Full Text] [Related]
18. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides. Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion. Zhu Z; Li R; Xiao G; Chen Z; Yang J; Zhu Q; Liu S Eur J Med Chem; 2012 Nov; 57():211-6. PubMed ID: 23059548 [TBL] [Abstract][Full Text] [Related]
20. Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus. Li H; Chen L; Li S; Liao Y; Wang L; Liu Z; Liu S; Song G Bioorg Med Chem Lett; 2019 Sep; 29(18):2675-2680. PubMed ID: 31371135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]